LSE:ERGO (Ergomed plc)
About ERGO
Ergomed PLC is engaged in the healthcare sector. Its business involves the provision of drug development services to the pharmaceutical industry. The company operates through two segments: Clinical Research Outsourcing and Pharmacovigilance. It provides clinical development services to clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. The PV segment has expertise in the field of pharmacovigilance and provides medical information services.
Ergomed plc (LSE: ERGO) Latest News

Page
Investing in Genetics: Top UK Genetics Stocks in 2022
Investing Articles
How I’d look to turn a £1,000 investment in UK growth shares into £5,000

Investing Articles
2 UK biotech stocks to watch in 2021
Investing Articles
Alongside AstraZeneca, I’d buy this small-cap share in the pharmaceutical sector
Investing Articles
AstraZeneca and this small growth pharma stock could make you brilliantly rich

Investing Articles
GlaxoSmithKline plc isn’t the only pharma stock worth investing in for retirement
Investing Articles
A small-cap growth stock I’d buy alongside Premier Oil plc in 2018
